 Hepatitis C Virus (HCV) for Egyptian patients Data Set
Download: Data Folder, Data Set Description

Abstract: Egyptian patients who underwent treatment dosages for HCV about 18 months. Discretization should be applied based on expert recommendations; there is an attached file shows how.




Data Set Information:

Provide all relevant information about your data set.

Attribute Information:

Age Age
Gender Gender
BMI Body Mass Index
Fever Fever
Nausea/Vomting Nausea/Vomting
Headache Headache
Diarrhea Diarrhea
Fatigue & generalized bone ache Fatigue & generalized bone ache
Jaundice Jaundice
Epigastric pain Epigastric pain
WBC White blood cell
RBC red blood cells
HGB Hemoglobin
Plat Platelets
AST 1 aspartate transaminase ratio
ALT 1 alanine transaminase ratio 1 week
ALT 4 alanine transaminase ratio 12 weeks
ALT 12 alanine transaminase ratio 4 weeks
ALT 24 alanine transaminase ratio 24 weeks
ALT 36 alanine transaminase ratio 36 weeks
ALT 48 alanine transaminase ratio 48 weeks
ALT after 24 w alanine transaminase ratio 24 weeks
RNA Base RNA Base
RNA 4 RNA 4
RNA 12 RNA 12
RNA EOT RNA end-of-treatment
RNA EF RNA Elongation Factor
Baseline histological Grading Baseline histological Grading
Baselinehistological staging Baselinehistological staging